Will Medicare Cover Insulin?

For decades, insulin costs have been a source of anxiety for Medicare beneficiaries living with diabetes. While Medicare has covered insulin in certain situations for years, many people still faced steep monthly bills—often over $200. That changed in 2023 when the Inflation Reduction Act set a $35 monthly copay cap for covered insulin under both Part B and Part D. The cap applies all year long, even during the coverage gap (the “donut hole”), and is calculated separately for each insulin type you use.

Today, most Medicare patients pay no more than $35 per month for their insulin, whether it’s delivered through a vial and syringe, an insulin pen, or an insulin pump. For the more than 3.3 million Medicare Part D enrollees who use insulin, the change has eased financial strain and made it easier to stick with treatment.The exact rules still depend on your delivery method, plan type, and whether your insulin is included in your plan’s formulary.

Medicare Insulin Coverage Basics

Medicare’s insulin benefits are split across different parts of the program, and the way your insulin is delivered determines which part applies. Understanding these distinctions is the first step to knowing exactly how your coverage works.

How Medicare Covers Insulin

Medicare coverage depends largely on the delivery method:

• Under the Inflation Reduction Act, all covered insulin under both parts is subject to the $35 monthly copay cap, regardless of brand or insulin type.
• Part B covers insulin when used with a Medicare-approved insulin pump (classified as durable medical equipment) or, in some cases, when administered during a clinical visit. The $35 monthly cap applies only to insulin dispensed for use with a covered pump, not to doses given in an emergency or outpatient setting.
• Part D—through standalone Medicare Part D plans or Medicare Advantage plans with drug coverage—covers most insulin obtained from a retail pharmacy, including vials, pens, cartridges, and inhaled products like Afrezza. Disposable patch pumps such as Omnipod are also covered under Part D if your plan includes them, but the device and the insulin may have separate formulary listings, copays, or prior authorization rules.
• Under the Inflation Reduction Act, all covered insulin under both parts is subject to the $35 monthly copay cap, regardless of brand or insulin type.

Because the cap applies year-round, even during the coverage gap, beneficiaries can better predict their monthly insulin costs and avoid unexpected spikes.

Medicare Part B vs Part D Insulin Coverage

For insulin used with a Medicare-covered durable pump, Part B coverage is capped at $35 per month per insulin type, and the Part B deductible does not apply. That benefit extends to related supplies like infusion sets and reservoirs.

Part D coverage follows your plan’s copay or coinsurance rules but applies the $35 maximum in every phase of the plan year. Some beneficiaries may have insulin covered under both parts—typically when they use more than one delivery method, such as pump insulin billed under Part B and pen or vial insulin billed under Part D.

Medicare Advantage plans must match these protections, meaning patients in private plans get the same capped rates as those in Original Medicare with Part D.

Medicare Insulin Approval Requirements

Before Medicare will cover your insulin, you must meet certain medical and administrative criteria. These rules confirm that insulin therapy is necessary and that the prescribed type and dosage fit your health needs.

Medical Necessity Requirements

To qualify for Medicare-covered insulin, you must have a documented diabetes diagnosis—whether Type 1, Type 2, or another form that requires insulin—and a prescription from a qualified provider. Supporting records typically include:

• Blood glucose monitoring results and HbA1c levels.
• Treatment history showing how your condition has been managed to date.
• In some cases, proof that you’ve tried other diabetes medications first.

Ongoing coverage also depends on regular follow-up visits and documentation that your glucose levels are being monitored and managed effectively.

Prescription and Documentation Process

Once insulin is prescribed, your provider will specify the exact type, dosage, frequency, and delivery method. From there, you or your provider should confirm that the insulin is on your plan’s formulary and, if it’s a non-preferred brand, request prior authorization. Plans may have monthly quantity limits and refill timing rules, which you’ll need to follow to avoid interruptions. While generic insulin is often encouraged to lower costs, you can request brand-name coverage if your doctor documents a medical need.

Medicare-Covered Insulin Types and Diabetes Supplies

Medicare covers more than the insulin itself—it also includes key supplies and devices that make daily management possible. Knowing which benefits fall under Part B versus Part D can help you avoid surprise charges.

Insulin Types and Delivery Methods

Most self-administered prescription insulin—vials, pens, and cartridges—falls under Part D. Insulin for use with a Medicare-covered pump is billed under Part B, along with pump-related supplies such as infusion sets and reservoirs. Some beneficiaries also qualify for coverage of continuous glucose monitors, including sensors and transmitters, when they are part of an insulin therapy plan. This broader coverage ensures that patients have both the medication and the tools necessary for effective diabetes control.

Medicare Diabetes Management Supplies

Managing diabetes safely requires consistent access to monitoring equipment and emergency resources. Medicare supports this through coverage for:

• Blood glucose meters (basic and advanced) and matching test strips in quantities suited to your prescribed testing frequency.
• DSMT (Diabetes Self-Management Training) programs that teach effective care and prevention strategies.
• Emergency glucagon kits when prescribed, often with benefits that extend during travel or temporary moves—if the product appears on your plan’s formulary.

These benefits work alongside insulin coverage to make daily blood sugar management more reliable and less financially stressful.

Medicare Insulin Costs and $35 Cap

The biggest shift in insulin affordability for Medicare beneficiaries came with the $35 monthly maximum, introduced under the Inflation Reduction Act. This cap applies separately to each covered insulin type and remains in place all year, including during the “donut hole” coverage gap. For many, it’s meant the difference between rationing doses and maintaining steady glucose control.

2025 Medicare Insulin Costs

Under Part B, insulin used with a Medicare-covered pump is normally subject to 20% coinsurance, but your cost is capped at $35 per month for each insulin type, and the Part B deductible does not apply. Other Part B services and supplies still require meeting the annual deductible (currently $257) before the standard 20% coinsurance applies.

Part D and Medicare Advantage (Part C) drug plans apply the $35 cap to most pharmacy-dispensed insulin throughout the year, regardless of coverage phase. This consistent cost-sharing structure means beneficiaries aren’t hit with surprise increases midway through the year, even if they require multiple insulin types.

The cap has also made it easier for people to plan their healthcare budgets. Before 2023, insulin users often saw their costs climb unpredictably during the coverage gap, sometimes exceeding $200 a month. Now, the only cost variations most people see are tied to their plan’s premiums or unrelated prescriptions.

Medicare Insulin Compliance and Monitoring Requirements

Keeping insulin coverage active requires more than just filling a prescription. Medicare expects beneficiaries to:

• See a physician regularly for diabetes management and insulin dose adjustments.
• Track blood glucose readings and keep records that demonstrate the medication’s effectiveness.
• Stay within the plan’s formulary or request exceptions for non-covered brands.

These compliance steps are designed to maintain both safety and cost efficiency. Following plan refill rules and reviewing coverage annually can also help you avoid unexpected denials or higher costs if your plan’s formulary changes.

Common Medicare Insulin Coverage Problems

Even with the $35 cap, some beneficiaries encounter coverage and access issues that can complicate insulin use. These can range from formulary restrictions to supply disruptions, and knowing about them ahead of time can help you avoid gaps in treatment.

Coverage and Access Issues

Many plans limit coverage to preferred brands or require prior authorization for certain insulin types. Some also restrict which pharmacies you can use for covered prescriptions. When combined with supply chain delays, these policies can create frustrating interruptions for people who depend on daily insulin. For those switching Medicare plans, there’s also the challenge of confirming that current prescriptions will still be covered after the transition.

Cost and Financial Concerns

The $35 copay cap has eased much of the financial burden, but some costs remain—especially for people using multiple types of insulin or additional diabetes medications. Beneficiaries can reduce out-of-pocket expenses by exploring:

• Supplemental coverage options, such as Medigap policies, that coordinate with Medicare benefits.
• Low-income assistance programs like Extra Help, which can further reduce drug plan premiums and copays.
• Manufacturer savings initiatives, including the Lilly Insulin Value Program and Sanofi Patient Connection, may be available for those who qualify, though Medicare beneficiaries often face restrictions and must meet specific hardship or coverage-gap criteria.

These resources, along with Medicare’s protections, create a more predictable cost structure—but they still require proactive planning to get the most benefit.

How Solace Can Help with Medicare Insulin Coverage

Medicare’s insulin coverage rules are far better than they once were, but they’re still complex—especially when factoring in formularies, prior authorizations, and plan changes. Solace advocates work directly with patients to untangle these details, helping you get the right insulin at the lowest possible cost.

Insurance Navigation and Optimization

Advocates can identify the Medicare Part D or Medicare Advantage drug plan that best fits your insulin needs. This often involves:

• Comparing formularies to confirm your prescribed insulin is covered.
• Managing prior authorization requests for specific brands or delivery methods.
• Coordinating benefits if you have supplemental or secondary coverage.

This kind of targeted guidance ensures you aren’t overpaying or stuck in a plan that limits your access to the insulin you need.

Access and Compliance Support

Once your coverage is set, Solace can help keep it running smoothly. Advocates coordinate with doctors and pharmacies to arrange timely refills, set up supply deliveries, and troubleshoot problems like delayed shipments. They can also connect you with manufacturer and nonprofit assistance programs—such as getinsulin.org, the Lilly Cares Foundation, and RxAssist—to reduce costs further. By having someone track your prescriptions, delivery schedules, and insurance rules, you’re less likely to face last-minute shortages or unexpected denials.

Frequently Asked Questions About Medicare Insulin Coverage

Does Medicare cover all types of insulin?

Yes. Rapid-acting, long-acting, and intermediate-acting insulins are all covered, subject to the $35 monthly cap per insulin type. This includes both brand-name and generic versions, as long as the product is on your plan’s formulary.

What if my insulin isn’t on my plan’s formulary?

Medicare drug plans must cover at least one product in each insulin category. If your prescribed insulin isn’t covered, you can request a formulary exception, supported by medical documentation from your provider.

Can I get a 90-day supply of insulin?

Many Part D plans allow 90-day refills. The $35 monthly limit still applies, which could mean $105 for a 3-month supply. Some plans may offer mail-order options for these larger refills, which can be more convenient for ongoing use.

What happens if I need multiple types of insulin?

The $35 limit applies separately to each type—so you may pay $35 per month for each. For example, if you use both a rapid-acting and a long-acting insulin, each will have its own $35 cap.

Is insulin covered during the Medicare Part D coverage gap?

Yes. The $35 cap continues during the Part D “coverage gap” phase. Many describe the “donut hole” as closed, but the phase still exists—it just no longer comes with higher cost-sharing. With the cap, insulin prices stay the same during this period.

Do I need prior authorization for insulin?

Plans may require prior authorization, step therapy, or quantity limits for certain covered insulin products. If your prescribed insulin isn’t on the plan’s list, you can request an exception with medical documentation from your provider.

What if I use an insulin pump?

Pump supplies are covered under Part B as durable medical equipment, while the insulin itself may fall under Part B or Part D. If it’s billed under Part B, the $35 monthly cap applies, and after meeting the annual deductible, you typically pay 20% coinsurance for other covered pump-related services and supplies.

Are diabetes testing supplies covered separately?

Yes. Meters, test strips, and lancets are covered as distinct benefits with their own cost-sharing rules. By combining Medicare’s $35 copay cap with the right plan selection, careful documentation, and—if needed—Solace advocate support, beneficiaries can keep insulin costs predictable and access consistent, no matter their delivery method or brand preference.

This article is for informational purposes only and should not be substituted for professional advice. Information is subject to change. Consult your healthcare provider or a qualified professional for guidance on medical issues, financial concerns, or healthcare benefits.

‍